10-hydroxycarbamazepine has been researched along with Trigeminal Neuralgia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boas, J; Dam, M; Flesch, G; Jensen, PK; Jórgensen, L; Mogensen, PH; Vesterager, A | 1 |
| Elyas, AA; Patsalos, PN; Zakrzewska, JM | 1 |
| Farago, F | 1 |
1 trial(s) available for 10-hydroxycarbamazepine and Trigeminal Neuralgia
| Article | Year |
|---|---|
Trigeminal neuralgia: its treatment with two new carbamazepine analogues.
Topics: Adult; Aged; Aged, 80 and over; Carbamazepine; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Oxcarbazepine; Trigeminal Neuralgia | 1987 |
2 other study(ies) available for 10-hydroxycarbamazepine and Trigeminal Neuralgia
| Article | Year |
|---|---|
Effects of dextropropoxyphene on the steady-state kinetics of oxcarbazepine and its metabolites.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Dextropropoxyphene; Dose-Response Relationship, Drug; Drug Therapy, Combination; Epilepsy; Female; Humans; Male; Middle Aged; Oxcarbazepine; Trigeminal Neuralgia | 1992 |
Protein binding of oxcarbazepine and its primary active metabolite, 10-hydroxycarbazepine, in patients with trigeminal neuralgia.
Topics: Adult; Aged; Blood Proteins; Carbamazepine; Female; Humans; Male; Middle Aged; Oxcarbazepine; Protein Binding; Trigeminal Neuralgia | 1990 |